FindTrial
Sign In

Multimodal ultrasound-based radiopathomics for early classification of triple-negative breast cancer and prediction of chemotherapy efficacy, a prospective multicenter study

Multimodal Ultrasound-based Radiopathomics for Precise and Quantitative Analysis on Triple-Negative Breast Cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400087663
Enrollment
Unknown
Registered
2024-08-01
Start date
2024-08-10
Completion date
Unknown
Last updated
2024-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Triple-Negative Breast Cancer

Interventions

Triple-Negative Breast Cancer group/ Non Triple-Negative Breast Cancer group:None

Sponsors

Changsha Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Women with suspected breast cancer detected by ultrasound; 2. Ultrasound-guided puncture biopsy after breast ultrasound examination; 3. Surgery and obtaining pathology after biopsy.

Exclusion criteria

Exclusion criteria: 1. History of ipsilateral breast cancer with preoperative systemic therapy or radiotherapy; 2. The maximum diameter of the tumor exceeded the ultrasonic detection range (clinical stage was T3-T4 tumor); 3. Diagnosis of benign lesions or carcinoma in situ by puncture biopsy or surgical pathology; 4. Lymphoma or metastatic tumor; 5. Lack of surgical specimen or lack of immunohistochemical results; 6. Incomplete ultrasound images.

Design outcomes

Primary

MeasureTime frame
pathology results;2D ultrasound lesion size;—

Secondary

MeasureTime frame
Clinical staging before treatment and pathological staging after treatment;Presence of complications;—

Countries

China

Contacts

Public ContactZhiyi Chen

Changsha Central Hospital

zhiyi_chen@usc.edu.cn+86 136 0976 8586

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026